Connect with us

Hi, what are you looking for?

Stock

Syngenta’s $10 billion Shanghai IPO to fund growth and acquisitions

Stock Markets16 minutes ago (Jul 02, 2021 10:55AM ET)

(C) Reuters. FILE PHOTO: A logo is seen at the headquarters of agricultural chemical maker Syngenta in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann

By Meg Shen and John Revill

HONG KONG/ZURICH (Reuters) -Syngenta Group will use the proceeds from its $10 billion initial public offering (IPO) to fund internal growth and an acquisition spree to snare more of the $100 billion market for seeds and sprays, the agrichemical giant said on Friday.

The company’s prospectus to list on Shanghai’s Nasdaq-style STAR Market was posted online by the Shanghai Stock Exchange on Friday, confirming details reported this week by Reuters after the application was filed on Wednesday.

“Syngenta Group will expand and renovate its production facility and implement strategic acquisition to meet growing market needs,” the company said in the document.

Syngenta said in the filing that its application to list on the STAR Market had been approved and it would issue up to 2.79 billion shares.

The flotation, set to be the world’s biggest this year, will value the maker of pesticides and seeds based in Basel, Switzerland, at about $60 billion including debt, or $50 billion without, sources have told Reuters.

The filing means the flotation is likely to take place by the end by 2021, said the sources, who were not authorised to speak to media and declined to be identified.

A secondary listing for Syngenta is also being considered that could take place less than a year after its debut, with exchanges in Zurich, London and New York among the options being examined, the people said.

Proceeds will fund acquisitions, including deals already announced to buy Yangnong Agrochemical and Valagro, the filing said.

Cash raised will also be used on other projects such as advanced agricultural technology research, production expansion, and upgrading and maintaining its facilities.

Funds will also be used to expand further its modern agricultural service platform – which trains farmers in China – and to repay long-term debt, it said.

The Swiss seeds and crop protection giant was bought in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp this year.

The acquisition remains China’s biggest takeover of a foreign company and is aimed at using Syngenta’s top-tier chemicals and patent-protected seeds to drastically improve domestic agricultural output.

Since being taken over, Syngenta has been merged with Israeli agrochemical firm ADAMA and the fertiliser and seed business of Sinochem.

Syngenta, the world’s No.1 crop protection maker and No. 3 seed supplier, competes with Germany’s BASF, Bayer (OTC:BAYRY) and U.S. agrochemicals company Corteva (NYSE:CTVA) in the speeds and sprays market.

The company employs 49,000 people globally and generated sales of $23.1 billion in 2020. Its biggest markets are the United States and Brazil, while it is growing rapidly in China.

Syngenta reported first-quarter sales of $7.1 billion, 20% higher year-on-year, with earnings before interest, tax, depreciation and amortisation rising 19% to $1.5 billion.

Net profit rose 72% in the first quarter, the prospectus said.

($1 = 6.4705 Chinese yuan renminbi)

Syngenta’s $10 billion Shanghai IPO to fund growth and acquisitions

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Stock

Stock Markets25 minutes ago (Jul 16, 2021 05:46PM ET) (C) Reuters. FILE PHOTO: Johnson & Johnson’s Neutrogena Cool Dry Sport sunscreen, which is part...

Tech

Builders, creators and developers, this one’s for you! TechCrunch has always been about discovering fresh solutions and shining the light on exciting, new products...

Disclaimer: Wisegazette.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved